BioStock: Enzymatica’s CEO comments on his resignation
Refinitiv閱讀少於1分鐘
Claus Egstrand is stepping down as CEO of Enzymatica and will transition to a new role on the company’s Board of Directors. Having been part of Enzymatica since 2017 and having served as CEO since 2021, Egstrand has played a key role in driving the company’s scientific and commercial progress.
Read the article at biostock.se:
https://biostock.se/en/2025/07/enzymaticas-ceo-comments-on-his-resignation/
登入或建立一個永久免費帳戶來閱讀此新聞